Huadong Medicine Co Ltd
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
34 / 178
Position in country
706 / 7387
Return on Assets, %
8.4
2.4
Net income margin, %
7
1.5
EBITDA margin, %
11.7
4.6
Debt to Equity, %
19.4
35.4
Intangible assets and goodwill, %
16.7
1.8
Revenue CAGR 3Y, %
2
8.3
P/E
18.7
17.4
P/BV
2.4
1.2
P/S
1.2
0.6
EV/S
1.2
0.8
EV/EBITDA
13.9
8.6
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
83.2
20.7
Forward P/E
14.3
13.1
Forward Dividend Yield, %
0.2
0.5
Expected dividend per share
0
0.1
Payout Ratio, %
19.6
30.7
Competitors
Ranks
-
China National Medicines Corp Ltd
00%
-
China National Accord Medicines Corp Ltd
00%
-
Tibet Rhodiola Pharmaceutical Holding Co
00%
-
Huadong Medicine Co Ltd
00%
-
Qingdao Baheal Medical Inc
00%
-
Jointown Pharmaceutical Group Co Ltd
00%
-
Sinopharm Group Co Ltd
00%
-
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
00%
-
Shanghai Pharmaceuticals Holding Co Ltd
00%
-
China Meheco Group Co Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
China
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Providers & Services
Sub-sector
Health Care
Capitalization (millions of $)
7029.6
Ticker
000963.SZ
ISIN
CNE0000011S1
IPO date
2000-01-27
Availability on Russian exchanges
No
Reporting for
2023-08-15
Date fact. publication of reports
2023-06-30
Company Description
HUADONG MEDICINE CO., LTD is a China-based comprehensive pharmaceutical company. The Company is mainly engaged in the research and development of pharmaceuticals, the production and sales of chemical drugs, bulk drugs and preparations of traditional Chinese medicine, the distribution and retails of pharmaceuticals, medicine modern logistics, health industry, and the manufacturing and sales of medical beauty products. The Company's products principally include Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs and antibiotic drugs. The Company distributes its products in domestic market and to overseas markets.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: